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While the developed world has seen a significant increase in the number of scientific
articles on Clostridium difficile infection (CDI), the developing world still lags behind on
this subject due to limited laboratory capacity, low awareness, and limited surveillance
of this problem. As such, CDI is considered a neglected but potentially huge problem
in developing countries. The major aim of this study was to systemically evaluate
the utility of several molecular typing tools for CDI, including their relevance in
epidemiological studies in developing countries such as China. A total of 116 non-
repetitive toxigenic C. difficile isolates from Chinese patients, were studied. The isolates
comprised 83 (71.6%) A+B+CDT− isolates, 27 (23.3%) A−B+CDT− isolates, and 6
(5.1%) A+B+CDT+ isolates. Typing methods evaluated included multilocus variable-
number tandem-repeat analysis, PCR ribotyping, multilocus sequence typing, and
sequencing of slpA and tcdC genes, which identified 113, 30, 22, 18, and 8 genotypes
each and exhibited discriminatory powers of 0.999, 0.916, 0.907, 0.883, and 0.765,
respectively. Compared to A+B+ strains, A−B+ strains exhibited higher prevalence
of drug resistance to clindamycin, erythromycin, levofloxacin, rifampicin, rifaximin, and
tetracycline. Furthermore, drug resistance rates of strains with different PCR ribotypes
differed, supporting the importance of molecular typing in management and control of
CDI. Based on our earlier suggestion to improve the diagnostic laboratory capacity of
CDI in developing countries, setting up efficient surveillance programs complemented
by relevant molecular typing methods is warranted.
Keywords: Clostridium difficile, molecular typing, antimicrobial resistance, surveillance, China
INTRODUCTION
Clostridium difficile is a leading cause of both nosocomial and antibiotic-associated diarrhea. The
clinical manifestation of C. difficile infection (CDI) ranges from asymptomatic colonization to mild
diarrhea to toxic megacolon and fulminant colitis. CDI is now considered a public health threat,
with a dramatic rise in the incidence and severity of CDI observed in Europe and North America
in the past two decades (Rupnik et al., 2009).
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Most CDI cases have largely been attributed to the presence
of the hyper-virulent C. difficile strain BI/NAP1/027 [restriction
endonuclease analysis (REA) group BI, North American pulse-
field type 1, PCR ribotype 027; McDonald et al., 2005].
Although ribotype 027 strains have caused major epidemics
in North America and Europe, only sporadic cases have
been reported in Asia (Collins et al., 2013). The major
virulence factors for C. difficile are enterotoxin A (TcdA)
and cytotoxin B (TcdB) (George et al., 1978). However,
some strains that produce a binary toxin called C. difficile
binary toxin (CDT), and whose role in causing disease
is not yet clear, have been described and are associated
with increased virulence and recurrence rates (Popoff et al.,
1988).
Knowledge of the antimicrobial susceptibility profiles and
molecular types of C. difficile is an important first step
for monitoring and understanding the epidemiology of this
organism. A variety of molecular methods have been applied
for genotyping of C. difficile, including PCR ribotyping,
pulsed-field gel electrophoresis (PFGE), multilocus sequence
typing (MLST), multilocus variable-number tandem-repeat
analysis (MLVA), and sequencing of functional genes such as
slpA and tcdC (Collins et al., 2015). Each of these typing
methods has its own merits and disadvantages, and may
be applied in different occasions according to the aim and
scale of the study (Killgore et al., 2008; Collins et al.,
2015).
In China, there are limited studies on the molecular
epidemiology and antibiotic susceptibility profiles of C. difficile,
possibly due to insufficient laboratory diagnostic capacity, low
awareness, and lack of high-quality surveillance systems
(Collins et al., 2013; Hawkey et al., 2013; Cheng et al.,
2015). However, in two previous retrospective studies,
PCR ribotype 027 isolates were detected, suggesting that
the threat of CDI in China is generally neglected and
possibly underestimated (Cheng et al., 2016). To partly
address this problem, we previously proposed a glutamate
dehydrogenase-based algorithm for improving the clinical
laboratory diagnostic capacity for CDI in China (Cheng et al.,
2015).
The objective of this study was to evaluate the utility of
different molecular typing assays for C. difficile, in relation
to toxigenicity and antimicrobial susceptibility, using isolates
obtained from one hospital in China. The usefulness of the
different assays in different situations was considered, to
inform decision making for improving the capacity of clinical
laboratories in the management of CDI in developing countries
like China.
MATERIALS AND METHODS
Ethics
The study was approved by the Human Research Ethics
Committee of Peking Union Medical College Hospital
(PUMCH) (No. PUMCHBC-C-4). Written informed consents
were obtained from patients for use of the samples in research.
Bacterial Isolates
A total of 116 non-duplicate toxigenic C. difficile isolates were
recovered from patients with suspected CDI in PUMCH between
August 2012 and July 2015. The majority of the isolates (69.0%;
80/116) were from the medical wards, followed by outpatient
or emergency department (22.4%; 26/116), surgical department
(6.0%; 7/116), and finally intensive care units (2.6%; 3/116).
All specimens were initially tested for toxin A/B using
enzyme immunoassay (EIA; VIDAS C. difficile Toxin A&B,
bioMérieux, Marcy l’Etiole, France) and cultured on selective
cycloserine–cefoxitin–fructose agar (CCFA) plates. Typical
colonies on CCFA were identified as C. difficile by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS; Bruker Daltonics GmbH, Bremen, Germany).
Only C. difficile isolates obtained from stool specimens with
positive EIA results, and confirmed by MALDI-TOF MS, were
included in the study.
DNA Extraction, Toxin Gene Detection,
and Sequencing of tcdC Gene
DNA extraction and subsequent toxin gene detection was carried
out as previously described (Cheng et al., 2015). Genotype of tcdC
gene was determined by comparing the obtained sequences with
previous published sequences as described by Curry et al. (2007).
Molecular Type Assays
Capillary sequencer-based PCR ribotyping was performed as
described by Indra et al. (2008), and ribotypes were assigned
by querying the results against WEBRIBO database1. Novel
ribotypes were named as “PUR” plus two Arabic numbers (e.g.,
PUR01).
Multilocus sequence typing was performed by sequencing
seven house-keeping gene loci as previously described by Griffiths
et al. (2010), and sequence type (ST) and clades of C. difficile
isolates were determined by querying on official website2.
Multilocus variable-number tandem-repeat analysis was
performed using the set of seven loci as proposed by van den Berg
et al. (2007). Repeat numbers were analyzed using BioNumerics
software v6.5 (Applied Maths, Texas, USA) for cluster analysis.
Sequence typing of the slpA gene was performed as described
previously by Kato et al. (2005). However, due to lack of
a consistent nomenclature for slpA genotypes, different slpA
genotypes and subtypes were defined as per NCBI database
GenBank accession entries for slpA genotype descriptions (Joost
et al., 2009).
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was performed by the
agar dilution method according to Clinical and Laboratory
Standards Institute (CLSI) guidelines (document M11-A8;
CLSI, 2012). The following 11 antimicrobial agents were
used: ciprofloxacin, clindamycin, erythromycin, levofloxacin,
meropenem, metronidazole, piperacillin/tazobactam, rifampicin,
1https://webribo.ages.at/
2http://pubmlst.org/cdifficile/
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rifaximin, tetracycline, and vancomycin. Interpretation of testing
results was based on CLSI M100-S25 (CLSI, 2015), or according
to the criteria suggested by Huang et al. (2009) for the drugs
whose breakpoints were not available in CLSI documents, as
summarized in Supplementary Table S1. Bacteroides fragilis
ATCC 25285 was used for quality control.
Data Analysis
The genetic relationships of the isolates was determined by
cluster analysis using the minimum-spanning tree available in the
BioNumerics software v 6.5 (Applied Maths).
To compare the discriminatory power of different molecular
methods, we used an index of discriminatory power (D) based on
Simpson’s index of diversity (Fawley et al., 2015).
Statistical analyses were performed using SPSS software
(version 17.0, IBM, New York, NY, USA). The chi-square test was
applied to compare categorical variables. The level of statistical
significance was defined as P < 0.05.
RESULTS
Toxigenic Types and tcdC Genotype
Of the 116 toxigenic strains studied, 83 (71.6%) were tcdA-
positive, tcdB-positive, and cdtA/cdtB-negative (A+B+CDT−),
while 27 (23.3%) were tcdA-negative, tcdB-positive, and
cdtA/cdtB-negative (A−B+CDT−). The remaining six (5.1%)
isolates were tcdA-positive, tcdB-positive, and cdtA/cdtB-positive
(A+B+CDT+; Table 1).
Seven previously described tcdC STs were identified, including
tcdC-0 (40 isolates, 34.5%), tcdC-B (1 isolate, 0.86%), tcdC-
sc1 (2 isolates, 1.7%), tcdC-sc3 (17 isolates, 14.7%), tcdC-sc7
(26 isolates, 22.4%), tcdC-sc9 (26 isolates, 22.4%), and tcdC-
sc15 (1 isolate, 0.9%). One novel tcdC genotype (3 isolates,
2.5%) was also identified, and was identical to sequence
JF719680 deposited in the GenBank and named as tcdC-
puc1. Three genotypes, including tcdC-sc1, tcdC-B, and the
novel genotype tcdC-puc1, had an 18-bp deletion at position
330–347, which is characteristic of ribotype 027. In addition,
the two tcdC-sc1 isolates had a single-nucleotide deletion at
position 117.
MLST
The 116 strains were classified into 22 STs. ST54 was the most
common (n = 19, 16.4%), followed by ST3 (n = 17, 14.7%),
ST37 (n = 16, 13.8%), ST2 and ST81 (n = 11, 9.5% each), whilst
other STs were rare (prevalence<8%). Two novel STs, ST333 and
ST334, were identified (Table 1). The majority of isolates (n= 82,
70.1%) belonged to clade 1, followed by clade 4 (n = 28, 24.1%),
and only three isolates each belonged to clades 2 and 3 (Table 1).
slpA Genotypes
By slpA sequencing, the 116 isolates were discriminated into 13
major genotypes and 18 subtypes (Table 1). The dominant slpA
genotype was fr-01 (n = 24, 20.7%), followed by kr-03 (n = 21,
18.1%), gr-01 (n = 17, 14.7%), yok-01 and hr-01 (n = 11, 9.5%
each). Two novel slpA subtypes, namely pus1-01 and pus2-01,
were identified in the present study.
Capillary Sequencer-Based PCR
Ribotyping
Thirty different PCR ribotypes were identified. The dominant
ribotype was 012 (n = 19, 16.4%), followed by ribotype 001
(n = 17, 14.7%), and ribotype 017 (n = 16, 13.8%; Table 1).
Strains of the hyper-virulent PCR ribotype 027 (n= 2, 1.7%) were
also detected. Other previously undocumented ribotypes, which
we designated PUR01–PUR17, were detected. Of these novel
ribotypes, ribotype PUR09 exhibited higher prevalence (n = 11,
9.5%) whilst the prevalence of each of the other ribotypes was low
(0.9–3.4%; Table 1).
MLVA
Using the seven loci for MLVA typing, namely A6, B7, C6,
E7, F3, G8, and H9, we identified 35, 24, 37, 11, 6, 28,
and 3 different alleles, amongst 116 isolates, respectively. By
combination analysis of the seven loci, a total of 113 different
MLVA types were identified (Figure 1D). None of the MLVA
types identified comprised more than three isolates each.
Relatedness of Genotypes Determined
by Different Typing Methods
Of the different typing methods used, MLVA exhibited the
greatest discriminatory power, generating a D-value of 0.999,
followed by PCR ribotyping (D-value 0.916) and MLST (D-value
0.907). In comparison to the above, slpA and tcdC sequencing
exhibited lower discriminatory power (D-value 0.883 and 0.765,
respectively; Table 2).
Of note, there was a strong correlation between toxigenic
types and MLST clades: all 82 MLST clade 1 isolates were
A+B+CDT−. Among 28 MLST clade 4 isolates, 27 (96.4%) were
of toxigenic type A−B+CDT− and only one isolate (3.6%) was
A+B+CDT−. Furthermore, all A+B+CDT+ isolates were only
found in MLST clades 2 and 3 (Table 1).
There was also some association between tcdC genotyping
results and MLST clades: tcdC-WT (39/82, 47.6%) and tcdC-sc9
(25/82; 30.5%) isolates were the commonest tcdC genotype in
MLST clade 1, and were rarely represented (one isolate each)
in other MLST clades. All the 17 A+B+CDT− isolates which
belonged to the second commonest ST in MLST clade 1, i.e.,
ST3 (17/82, 20.7%), were tcdC-sc3. In addition, 96.3% (26/27)
A−B+CDT− isolates were tcdC-sc7 (Table 1; Figure 1A).
Of 18 different slpA genotypes/subtypes identified, only two
were shared by different MLST clades, namely hr-01 shared by
MLST clade 1 (n = 10) and clade 4 (n = 1), and kr-04 shared by
MLST clade 1 (n = 1) and clade 3 (n = 1). Other slpA genotypes,
although shared by different MLST STs, were unique amongst
MLST clades (Table 1; Figure 1B).
PCR ribotyping exhibited higher discriminatory power than
MLST, and none of the PCR ribotypes were shared by different
MLST clades (Figure 1C). Four ribotypes were identified
amongst six A+B+CDT+ isolates. The two ribotype type 027
isolates, which have been previously reported by our group
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TABLE 1 | Multilocus sequence typing (MLST), ribotype, slpA, tcdC, and toxin genotypes of the 116 Clostridium difficile clinical isolates.
MLST clade MLST ST Ribotype slpA genotype tcdC genotype Toxin gene No. of isolates
Clade 1 ST2 14 hr-01 sc9 A+B+CDT− 2
WT A+B+CDT− 4
pus1-01 WT A+B+CDT− 1
20 hr-01 sc9 A+B+CDT− 1
WT A+B+CDT− 1
PUR02 hr-01 sc9 A+B+CDT− 1
PUR03 cc12078-01 WT A+B+CDT− 1
ST3 1 gr-01 sc3 A+B+CDT− 17
ST8 2 yok-01 WT A+B+CDT− 3
PUR04 yok-01 WT A+B+CDT− 1
PUR05 yok-01 WT A+B+CDT− 4
ST27 39 sh-01 WT A+B+CDT− 1
ST35 46 og39-01 WT A+B+CDT− 8
ST42 106 hr-02 WT A+B+CDT− 5
ST51 PUR07 yok-01 Ba A+B+CDT− 1
ST54 12 kr-03 sc9 A+B+CDT− 16
WT A+B+CDT− 3
ST55 70 kr-04 sc9 A+B+CDT− 1
PUR08 kr-03 sc9 A+B+CDT− 1
ST91 PUR10 ar-01 WT A+B+CDT− 1
ST98 PUR11 pus1-01 WT A+B+CDT− 1
ST129 PUR13 xr-03 sc9 A+B+CDT− 1
WT A+B+CDT− 1
ST233 PUR14 yok-01 sc9 A+B+CDT− 1
ST278 PUR15 kr-03 WT A+B+CDT− 1
ST286 PUR16 pus2-01 WT A+B+CDT− 1
ST289 PUR17 hr-01 sc9 A+B+CDT− 1
ST333 2 yok-01 WT A+B+CDT− 1
ST334 PUR12 gc11-01 WT A+B+CDT− 1
Clade 2 ST1 27 gc8-03 sc1a A+B+CDT+ 2
PUR01 gc8-03 WT A+B+CDT+ 1
Clade 3 ST5 23 kr-04 puc1a A+B+CDT+ 1
63 j52-01 puc1a A+B+CDT+ 2
Clade 4 ST37 17 fr-01 sc7 A−B+CDT− 12
sc9 A−B+CDT− 1
fr-06 sc7 A−B+CDT− 3
ST81 PUR09 fr-01 sc7 A−B+CDT− 11
ST332 PUR06 hr-01 sc15 A+B+CDT− 1
atcdC-sc1, tcdC-B, and tcdC-puc1 had 18-bp deletion at position 330–347; tcdC-sc1 had a single-nucleotide deletion at position 117.
(Cheng et al., 2016), belonged to MLST ST1 (clade 2), slpA
genotype gc8-03, and tcdC genotype tcdC-sc1 (having 18-bp
deletion at position 330–347, and single-nucleotide deletion at
position 117 versus wild-type; Table 1). However, the PUR01
(n= 1) A+B+CDT+ isolate, which although belonged to MLST
ST1 and was of slpA genotype gc8-03, carried the wild-type tcdC
gene (Table 1). In contrast, ribotype 63 (n = 2) and 23 (n = 1)
A+B+CDT+ isolates belonged to MLST ST5 (clade 3) and tcdC
genotype tcdC-puc1 (having 18-bp deletion at position 330–347,
but with no single-nucleotide deletion at position 117), but were
slpA genotype j52-01 and kr-04, respectively (Table 1). There
were only two ribotypes identified in 27 A−B+CDT− isolates,
namely ribotype 17 (n= 16, 59.3%) and ribotype PUR09 (n= 11,
40.7%; Table 1). Ribotypes identified in A+B+CDT− isolates
were much more diverse (24 ribotypes in 83 isolates), of which
ribotype 012 (n = 19, 22.9%) and 001 (n = 17, 20.5%) were the
commonest (Table 1).
Multilocus variable-number tandem-repeat analysis exhibited
the highest discriminatory power amongst all typing methods
used (Figure 1D). The minimum spanning tree generated by
MLVA also indicated a general phylogenetic relatedness of MLVA
typing results and MLST clades (Figure 1D). As can be seen
clearly in Figure 1D, using the MLVA spanning tree, MLST
clade 1 was separated into two major branches by MLST clade
4. However, discrepancies between MLVA and MLST were also
observed. For example, by MLVA analysis, the three MLST
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FIGURE 1 | Minimum spanning tree analysis based on allelic profiles of multilocus sequence typing (MLST) (A,B,C) and Multilocus variable-number
tandem-repeat analysis (MLVA) (D) data. Each circle in (A,B,C) corresponds to a MLST ST, and each circle in (D) corresponds to a MLVA genotype. Different
circle colors represent tcdC genotype, slpA genotype, PCR ribotype, and MLST clade in (A,B,C,D), respectively. The gray halo surrounding the MLST STs in (A–C)
denotes STs belonging to different MLST clades. The lines between circles indicate the similarity between profiles: bold line, six of seven MLST alleles/MLVA loci in
common; normal line, five alleles/loci in common; dashed line, four alleles/loci in common; dotted line, ≤3 alleles/loci.
ST1 isolates (red circles in Figure 1D) were classified into
two different branches: two isolates were more phylogenetically
related to MLST clade 3, but one isolate was more closely related
to MLST ST2 of MLST clade 1 (Figure 1D).
Antimicrobial Susceptibilities
The minimum inhibitory concentrations (MICs) of 11
antimicrobial agents for the 116 isolates are summarized in
Table 3. All the isolates were susceptible to metronidazole,
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TABLE 2 | Discriminatory power of the five typing methods used in this
study.
Method No. of
genotypes
Index of
discrimination
95% confidence
interval
MLVA 113 0.999 0.999–1
Ribotyping 30 0.916 0.895–0.938
MLST 22 0.907 0.888–0.926
slpA genotyping 18 0.883 0.858–0.908
tcdC genotyping 8 0.765 0.731–0.798
vancomycin, meropenem, piperacillin/tazobactam, but resistant
to ciprofloxacin. Co-resistance to erythromycin, clindamycin,
and levofloxacin was observed in 41.3% of the isolates. High-level
resistance to erythromycin (MIC > 128 mg/L) and clindamycin
(MIC > 128 mg/L) was detected in 63.8% and 55.2% of the 116
isolates, respectively. The MICs of rifampin were consistent with
those of rifaximin, and were either ≤0.064 mg/L or >256 mg/L.
Moreover, 25.9% of the isolates were resistant to tetracycline.
Drug resistance rates for A−B+ isolates for the antibiotics
levofloxacin, rifampicin, rifaximin, and tetracycline, were
significantly higher than that of A+B+ isolates (P < 0.001;
Table 3). In addition, varied antimicrobial resistance rates
were observed amongst different molecular types. For instance,
ribotypes 012, 017, and PUR09 isolates exhibited higher
resistance rates to clindamycin and erythromycin compared to
ribotype 001 and other ribotype isolates (Figure 2). Moreover,
ribotype 017 and PUR09 isolates showed higher prevalence rate
of resistance to levofloxacin and tetracycline, compared to other
ribotype isolates. Ribotype 017 isolates also had higher rate of
resistance to rifampicin and rifaximin (Figure 2).
DISCUSSION
Clostridium difficile infection has become a significant public
health threat in the developed world, with substantial increase in
morbidity and mortality reported since the early 2000s. However,
due to inadequate laboratory diagnostic capacity, little is known
about the magnitude of the CDI problem in developing countries
like China, and hence the problem may be much underestimated
(Collins et al., 2013; Hawkey et al., 2013; Cheng et al., 2016). In
this regard, our group has previously attempted to improve the
diagnosis of CDI in China by proposing a practical workflow
for future CDI laboratory diagnosis (Cheng et al., 2015).
Furthermore, the lack of high-quality CDI surveillance systems
and epidemiology studies in developing countries contributes to
the low awareness of CDI. Thus further studies are needed to
address this problem.
Molecular typing methods are essential for understanding the
epidemiology of C. difficile, and are especially important as part of
an active surveillance and hospital infection control strategy for
this organism. To date, several typing methods have been used to
study the epidemiology of C. difficile, and there are pros and cons
for each method. Most studies evaluating the utility of different
molecular typing methods for CDI are from the developed world.
In the present study, we evaluated the performance and utility TA
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FIGURE 2 | Drug resistance rates among different PCR ribotypes of 116 Clostridium difficile isolates.
of the most commonly used genotypic assays for C. difficile,
including toxigenic typing, tcdC genotyping, slpA genotyping,
MLST, PCR-ribotyping, and MLVA.
Although the dominant C. difficile toxigenic type is A+B+,
there has been an increase in the prevalence and significance
of the A-B+ type in some regions of the world (Kim et al.,
2008; King et al., 2015). In this study, 23.3% of the isolates were
A−B+CDT−, which is in agreement with previous studies in
China in which the average prevalence rate of A−B+ strains
is 21.4% (201/937), ranging from 0 to 53.6% by geographic
distribution (Huang et al., 2009, 2010; Dong et al., 2013; Hawkey
et al., 2013; Yan et al., 2013; Chen et al., 2014; Fang et al., 2014;
Wang et al., 2014; Zhou et al., 2014; Cheng et al., 2015; Ye
et al., 2015; Tian et al., 2016). Interestingly, infection with CDT-
positive C. difficile strains has been reported to be associated
with higher mortality and recurrence rates (Stewart et al., 2013).
In this study, 5.1% (6/116) isolates were A+B+CDT+, which
is slightly higher than in previous studies in Shanghai (1.6%,
2/110) and Zhejiang provinces (0%, 0/82; Huang et al., 2010; Fang
et al., 2014). However, the overall prevalence of A+B+CDT+
C. difficile strains in China is much lower than in North America
and Europe (Bassetti et al., 2012), possibly due to low lab
diagnostic capacity and subsequent lack of awareness amongst
medical personnel. By tcdC sequencing, five of six A+B+CDT+
isolates detected in this study had an 18-bp deletion at nucleotides
330–347, but only two ribotype 027 isolates, characterized by a
single deletion at nucleotide 117, were detected.
The predominant ribotype and ST identified in the present
study was ribotype 012/ST54 (16.4%), followed by ribotypes
001/ST3 (14.7%) and 017/ST37 (13.8%), whilst the commonest
ribotype is ribotype 012 reported overall in China (100 of 589
isolates, 17.0%), and ST54, ST3, ST35, and ST37 (prevalence of
21.4, 12.6, 11.0, and 9.4 of 682 isolates tested, respectively) rank
the top four STs (Huang et al., 2009, 2010; Dong et al., 2013;
Hawkey et al., 2013; Yan et al., 2013; Chen et al., 2014; Fang et al.,
2014; Wang et al., 2014; Zhou et al., 2014; Cheng et al., 2015; Ye
et al., 2015; Tian et al., 2016). The remaining ribotypes/STs were
distributed sporadically among different departments and with
a lower prevalence. Generally, there was no obvious correlation
between clonal clusters of the organism generated from the
different departments during the study period, suggesting that a
wide variety of strains are implicated in this hospital. However,
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TABLE 4 | Comparison and suggested usage of typing methods employed in the present study.
Typing method Reproducibility Inter-
laboratory
exchange
Discriminatory
power
Running
costs
Suggested usage
Toxigenic typing +++ ++ + + Toxin status confirmation and risk assessment for virulence
tcdC genotyping +++ + ++ + Hypervirulence strain detection
slpA genotyping +++ + ++ + Regional epidemiology for vaccine development
MLST +++ +++ ++ +++ Epidemiology surveillance (high costs); phylogenetic studies
Ribotyping +++ + ++ + Epidemiology surveillance (low costs); infection prevention and
control
MLVA +++ ++ +++ ++ Detection of local outbreaks
due to lack of consistent data and limited lab diagnostic capacity
for CDI at the hospital concerned, these findings may be biased.
Although the major molecular types identified in different
C. difficile studies were similar, the prevalence of different
molecular types varied amongst studies in China. In agreement to
our findings, ribotype 017 C. difficile strains have been reported
in several Asian countries (Collins et al., 2013). However,
in North America and Europe, many CDI cases have been
attributed to C. difficile ribotype 027 and 078 strains which
have been described in many hospitals, and were particularly
associated with outbreaks or epidemics (Bassetti et al., 2012).
The major clone implicated in epidemics varies according to
geographic locale, highlighting the significance of establishing a
local surveillance network for CDI.
The emergence of increased antibiotic resistance in different
C. difficile strain types worldwide may be a contributing factor
to increased occurrence of CDI outbreaks in several hospitals.
Although several studies have reported on the increasing MIC
for metronidazole and vancomycin in C. difficile (Baines et al.,
2008; Adler et al., 2015), both drugs showed high in vitro activity
against all the isolates in our study. Furthermore, all strains
were also susceptible to meropenem and piperacillin/tazobactam.
Although a small number (12.9%) of C. difficile strains with high-
level resistance to rifampin and rifaximin was observed in the
present study, the rate was lower than the 25–29% reported in
Shanghai, China (Huang et al., 2009, 2010).
The high rate of drug resistance for ciprofloxacin (100%),
erythromycin (69%), and clindamycin (87.9%) among the studied
isolates suggests that use of these antibiotics may be a risk factor
for the development of CDI in this geographic locale (Bassetti
et al., 2012). In addition, A−B+ strains in the present study
exhibited higher drug resistance rates compared to A+B+ strains
for the antibiotics clindamycin, erythromycin, levofloxacin,
rifampicin, rifaximin, and tetracycline. Thus toxigenic typing
may be valuable for understanding antibiotic resistance in
the management and control of CDI. Furthermore, the drug
resistance rates of strains of different PCR ribotypes differed.
These findings emphasize the importance of implementing active
surveillance and molecular epidemiologic studies on CDI.
All the typing methods used in this study have the advantage
of high reproducibility (Table 4). MLVA exhibited extremely high
discriminatory power, and thus may be a potential valuable tool
for investigating CDI outbreaks (Eyre et al., 2013b). However, a
reasonable cut-off value is needed since C. difficile isolates from
the same outbreak may belong to genetically closely related but
different MLVA types (Table 4) (Marsh et al., 2006).
Based on our findings, we recommend PCR ribotyping as the
method of choice for epidemiological surveillance and infection
prevention and control, as it delivers high discrimination,
accuracy, and reproducibility. However, more work is needed for
its standardization and database construction (Table 4) (Indra
et al., 2008; Fawley et al., 2015). Although MLST also offers
high discriminatory power index and easy inter-laboratory data
comparison which may be useful for epidemiology surveillance
and phylogenetic studies, the high cost is prohibitive (Table 4)
(Killgore et al., 2008; Collins et al., 2015; Tian et al., 2016).
Sequencing of the slpA gene is valuable for comparison of
C. difficile strains implicated in epidemics in diverse areas because
the typing results are reproducible and can easily be shared. In
addition, as the slpA gene is related to the strain’s serogroup,
this typing method could be useful in vaccine development
(Kato et al., 2005; Tian et al., 2016). tcdC genotyping had the
lowest D-value, but sequencing of this gene may be used as
an indicator for the hyper-virulent C. difficile clones, e.g., PCR
ribotype 027/078 isolates (Curry et al., 2007).
Several other C. difficile typing methods apart from the
ones applied in this study have been used, including PFGE,
REA, and PCR-restriction fragment length polymorphism
(RFLP). Unfortunately, these restriction enzyme-agarose gel
electrophoresis-based methods have poor reproducibility, and
are difficult to standardize for result interpretation and
inter-laboratory data exchange (Killgore et al., 2008; Collins
et al., 2015). Recent advances in whole-genome sequencing
of C. difficile has the potential to provide even greater
epidemiological information, but is still premature for use in
large scale epidemiologic studies (Eyre et al., 2013a; Knight et al.,
2015).
CONCLUSION
Our study is the most systematic study to integrate molecular
epidemiology and antibiotic susceptibility testing, and provides
comprehensive data for a better understanding of CDI in China.
The findings highlight the importance of active surveillance using
molecular typing techniques for better management and control
of CDI in developing countries. Different molecular typing assays
could be used depending on the scale and aim of the surveillance.
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